Differential binding of the HIV-1 envelope to phosphatidylserine receptors

por Gu, Linlin, Sims, Brian, Krendelchtchikov, Alexandre, Tabengwa, Edlue, Matthews, Qiana L.
Publicado 2017

Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

por Shea, Lauren K., Honjo, Kazuhito, Redden, David T., Tabengwa, Edlue, Li, Ran, Li, Fu-Jun, Shakhmatov, Mikhail, Chiorazzi, Nicholas, Davis, Randall S.
Publicado 2019

FCRL1 immunoregulation in B cell development and malignancy

por Mamidi, Murali K., Huang, Jifeng, Honjo, Kazuhito, Li, Ran, Tabengwa, Edlue M., Neeli, Indira, Randall, Nar’asha L., Ponnuchetty, Manasa V., Radic, Marko, Leu, Chuen-Miin, Davis, Randall S.
Publicado 2023

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency

por Honjo, Kazuhito, Russell, Ronnie M., Li, Ran, Liu, Weimin, Stoltz, Regina, Tabengwa, Edlue M., Hua, Yutao, Prichard, Lynn, Kornbrust, Ashton N., Sterrett, Sarah, Marques, Marisa B., Lima, Jose L., Lough, Chris M., McCarty, Todd P., Ketas, Thomas J., Hatziioannou, Theodora, Bieniasz, Paul D., Redden, David T., Moore, John P., Goepfert, Paul A., Heath, Sonya L., Hahn, Beatrice H., Davis, Randall S.
Publicado 2020